Astellas Archives -

Astellas, Seagen seek speedy reviews of Padcev in bladder cancer

https://pharmaphorum.com/news/astellas-seagen-seek-speedy-reviews-of-padcev-in-bladder-cancer/

Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovation

https://pharmaphorum.com/views-and-analysis/global-impact-how-regulatory-affairs-is-shaping-development-of-cutting-edge-pharma-innovation/

Astellas/Seagen prepare full US filing of bladder cancer drug Padcev

https://pharmaphorum.com/news/astellas-seagen-to-prepare-for-full-us-filing-of-bladder-cancer-drug-padcev/

Astellas doubles down on partnership and buys bioelectronics firm iota

https://pharmaphorum.com/news/astellas-doubles-down-on-partnership-and-buys-bioelectronics-firm-iota/

https://pharmaphorum.com/news/nice-backs-nhs-use-for-astellas-xospata-after-rethink/

GSK’s kidney disease anaemia drug approved in Japan, taking on Astellas’ rival

https://pharmaphorum.com/news/gsk-kidney-disease-anaemia-drug-approved-in-japan-taking-on-astellas-rival/

Seattle Genetics says data backs Padcev combo for first-line bladder cancer

https://pharmaphorum.com/news/seattle-genetics-says-data-backs-padcev-combo-for-first-line-bladder-cancer/

Xtandi takes fight to prostate cancer rivals with survival data

https://pharmaphorum.com/news/xtandi-takes-fight-to-prostate-cancer-rivals-with-survival-data/

Astellas to work with Adaptimmune to develop ‘off the shelf’ T-cell therapies

https://pharmaphorum.com/news/astellas-to-work-with-adaptimmune-to-develop-off-the-shelf-t-cell-therapies/

Search